TY - JOUR
T1 - Human immunodeficiency virus infection in advanced maternal age gravidas
AU - Brown, Kelecia
AU - Holland, Bart
AU - Mosquera, Claudia
AU - Calilap, Charmane
AU - Bardeguez, Arlene
PY - 2012/3/1
Y1 - 2012/3/1
N2 - Our study compares perinatal outcomes among HIV + versus HIV - advanced maternal aged (AMA) women. A retrospective cohort study of AMA deliveries from 2000 to 2009 was performed. HIV + (group A) women were compared to temporally matched HIV - (group B) women. Demographics, medical comorbidities, HIV treatment, and delivery data were collected. SAS was used for data analysis with p<0.05 considered significant. Seventy-one patients per study group were reviewed; for group A, the mean CD4 count near delivery was 507±363; 75% (34/45) had viral load ≤400 in the third trimester and 58% were on a protease inhibitor regimen. HIV + women had significantly higher preterm delivery (PTD) <37 weeks (A: 40.85%, B: 16.90%, p=0.0016). Logistic regression performed revealed that the odds of PTD was 2.83 (CI 1.22-6.54) for HIV + and 4.02 (CI 1.27-12.72) for drug use independent of other factors. The pathophysiology of PTD among HIV + AMA women warrants prospective examination to better define the causal relationship.
AB - Our study compares perinatal outcomes among HIV + versus HIV - advanced maternal aged (AMA) women. A retrospective cohort study of AMA deliveries from 2000 to 2009 was performed. HIV + (group A) women were compared to temporally matched HIV - (group B) women. Demographics, medical comorbidities, HIV treatment, and delivery data were collected. SAS was used for data analysis with p<0.05 considered significant. Seventy-one patients per study group were reviewed; for group A, the mean CD4 count near delivery was 507±363; 75% (34/45) had viral load ≤400 in the third trimester and 58% were on a protease inhibitor regimen. HIV + women had significantly higher preterm delivery (PTD) <37 weeks (A: 40.85%, B: 16.90%, p=0.0016). Logistic regression performed revealed that the odds of PTD was 2.83 (CI 1.22-6.54) for HIV + and 4.02 (CI 1.27-12.72) for drug use independent of other factors. The pathophysiology of PTD among HIV + AMA women warrants prospective examination to better define the causal relationship.
UR - http://www.scopus.com/inward/record.url?scp=84858124584&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858124584&partnerID=8YFLogxK
U2 - 10.1089/aid.2010.0365
DO - 10.1089/aid.2010.0365
M3 - Review article
C2 - 21801081
AN - SCOPUS:84858124584
SN - 0889-2229
VL - 28
SP - 265
EP - 269
JO - AIDS research and human retroviruses
JF - AIDS research and human retroviruses
IS - 3
ER -